Crossmark

Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States

Crossref DOI link: https://doi.org/10.1080/21645515.2018.1556077

Published Online: 2019-02-06

Published Print: 2019-08-03

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Islam, Jessica Y. https://orcid.org/0000-0002-3690-3848
Gruber, Joann F.

Kepka, Deanna

Kunwar, Manju

Smith, Sara B.

Rothholz, Mitchel C.

Brewer, Noel T. https://orcid.org/0000-0003-2241-7002
Smith, Jennifer S. https://orcid.org/0000-0002-1256-0422
Funding

Funding for this research was provided by:

Merck (VT ID #50873)

National Cancer Institute (F31-CA210474-01A1)

Merck and Co., Inc., Kenilworth, NJ USA (#50873)

NIH NRSA (F31-CA210474-01A1)
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=khvi20

Publication History

Received: 2018-10-05

Accepted: 2018-11-28

Published: 2019-02-06